Oak Street Health Securities Settlement
Recovery depends on the number of shares of Oak Street Health common stock purchased from August 6, 2020 through November 8, 2021, timing of purchases and sales, and whether purchased in the IPO, December SPO, or February SPO. Actual amount per share is explained in the Plan of Allocation.
This settlement is closed to new claims — the deadline was November 21, 2024. You can still see what it was about and follow the case in court below. Looking for money you can still claim? Browse open settlements →
What happened
Oak Street Health, Inc. allegedly violated securities laws by making false and misleading statements and omissions to investors concerning the company's patient acquisition tactics, including paying for referrals and marketing free transportation to prospective patients. The defendant has agreed to settle for $60,000,000 without admitting wrongdoing.
Do you qualify?
All persons and entities who purchased or acquired publicly traded common stock of Oak Street Health during August 6, 2020 through November 8, 2021, including those who purchased shares in the August 6, 2020 IPO, December 2, 2020 secondary public offering, or February 10, 2021 secondary public offering.
How to file
Submit a Claim Form (deadline November 21, 2024, which has passed). The claim form must document your purchase of Oak Street Health common stock during the class period. Contact the claims administrator at 1-877-753-2587 or info@OakStreetHealthSecuritiesSettlement.com for the claim form and instructions.
Common questions
- How much does the Oak Street Health Securities Settlement pay?
- Estimated payout: Recovery depends on the number of shares of Oak Street Health common stock purchased from August 6, 2020 through November 8, 2021, timing of purchases and sales, and whether purchased in the IPO, December SPO, or February SPO. Actual amount per share is explained in the Plan of Allocation.. The total settlement fund is $60M. Actual amounts depend on how many valid claims are filed — most settlements divide a fixed fund pro rata, so a higher claim rate means a smaller individual check. An "up to" figure is a cap, not a guarantee.
- What is the claim deadline for the Oak Street Health Securities Settlement?
- This settlement is closed to new claims — the deadline was November 21, 2024. Once a claim deadline passes you generally forfeit your share, even if you qualified.
- Do I need proof of purchase for the Oak Street Health Securities Settlement?
- Yes. This settlement asks for documentation supporting your claim — a receipt, an account record, or the notice you were sent. Check the official settlement website for exactly which documents are accepted.
- Is the Oak Street Health Securities Settlement notice real, or a scam?
- JND Legal Administration is the settlement administrator for this case. Claims are filed at oakstreethealthsecuritiessettlement.com. Filing a class action claim is always free — no legitimate settlement charges you to claim, and no administrator will ask for payment, a gift card, or your full Social Security number by email or text. If a notice asks for any of those, it is not from the administrator. When in doubt, ignore the link you were sent and go to the official settlement website directly.
- When will payments from the Oak Street Health Securities Settlement be sent?
- Class action payouts typically take 12 to 24 months after the claim deadline, and longer if the settlement is appealed. The final approval hearing for this case is set for December 12, 2024; no payments can be issued before a settlement receives final approval.
New to class actions?
This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.
More securities settlements
View all →Revance Securities Settlement
Revance Therapeutics and its executives made material misrepresentations and omissions regarding the company's relationship with Teoxane SA and the tender offer and merger transaction with Crown Laboratories, Inc., allegedly violating federal securities laws. Defendants deny any wrongdoing or liability.
Not yet determinable; depends on number of valid claims submitted
Biogen Securities Litigation Settlement
Biogen Inc. investors have settled a securities litigation case for $18.9 million in cash. The settlement resolves claims related to purchases of Biogen common stock during the specified class period.
NJ Bureau of Securities Settlement with Credit Suisse
Credit Suisse allegedly violated New Jersey Securities Law by making materially false and misleading statements regarding RMBS trust certificates and engaging in fraudulent practices. On October 24, 2022, the court entered a consent order requiring Credit Suisse to pay $300 million in restitution to investors. Credit Suisse neither admitted nor denied the allegations.
Stitch Fix Securities Litigation Settlement
Stitch Fix, Inc. is settling a securities class action lawsuit without admitting wrongdoing. The Lead Plaintiffs alleged that Stitch Fix issued misleading statements about its business, and shareholders who purchased the stock during the class period suffered damages as a result.